English

AXM PHARMA INC

EDGAR

Annual report amendment (10-K/A) · filed 2009-01-16

33 filing records in this dataset, filed from 2000-11-15 to 2009-01-16. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2006-03-31 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-120 thousand USD

2006-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -120190 USD Source

Free cash flow

-129 thousand USD

2006-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -120190 USD Source
Capital Expenditure: 9309 USD Source

Cash and cash equivalents: 13.6 thousand USD 2006-03-31 Source
Exact value

13620 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.99 million USD

2005-04-01 – 2006-03-31

Exact inputs and evidence

Revenue: 329042 USD · 2005-04-01 – 2005-06-30 Source
Revenue: 223713 USD · 2005-07-01 – 2005-09-30 Source
Revenue: 2021728 USD · 2005-01-01 – 2005-12-31 Source
Revenue: 581015 USD · 2005-01-01 – 2005-09-30 Source
Revenue: 0 USD · 2006-01-01 – 2006-03-31 Source

Net income

-12.4 million USD

2005-04-01 – 2006-03-31

Exact inputs and evidence

Net income: -1459352 USD · 2005-04-01 – 2005-06-30 Source
Net income: -3322395 USD · 2005-07-01 – 2005-09-30 Source
Net income: -11088281 USD · 2005-01-01 – 2005-12-31 Source
Net income: -7884040 USD · 2005-01-01 – 2005-09-30 Source
Net income: -4387397 USD · 2006-01-01 – 2006-03-31 Source

Operating cash flow

-6 million USD

2005-04-01 – 2006-03-31

Exact inputs and evidence

Operating cash flow: -5399298 USD · 2005-01-01 – 2005-06-30 Source
Operating cash flow: -2736086 USD · 2005-01-01 – 2005-03-31 Source
Operating cash flow: -8181996 USD · 2005-01-01 – 2005-09-30 Source
Operating cash flow: -5399298 USD · 2005-01-01 – 2005-06-30 Source
Operating cash flow: -8611869 USD · 2005-01-01 – 2005-12-31 Source
Operating cash flow: -8181996 USD · 2005-01-01 – 2005-09-30 Source
Operating cash flow: -120190 USD · 2006-01-01 – 2006-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2009-01-16.

Financial data available through: 2005-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2005-12-31
Operating income: 5 of 11 periods available· newest 2005-12-31
Net income: 7 of 11 periods available· newest 2005-12-31
Operating cash flow: 5 of 11 periods available· newest 2005-12-31
Capital expenditure: 6 of 11 periods available· newest 2005-12-31
Total assets: 7 of 11 periods available· newest 2005-12-31
liabilities: No compatible figures in this window
Current assets: 4 of 11 periods available· newest 2005-12-31
Current liabilities: 7 of 11 periods available· newest 2005-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2005-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-4.4%

Prior period

USD 2.12 million

2004-01-01 – 2004-12-31
Current period

USD 2.02 million

2005-01-01 – 2005-12-31

Exact inputs and evidence

2021728 − 2115751 = -94023 USD

2115751 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
2021728 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · AXM PHARMA INC · 2005-12-31 AXM PHARMA INC (edgar:1113643) Year-over-year change in Revenue: -94023 USD Concept: fundies:Revenue Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 2021728 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-06-000082.txt#3095 Input fundies:Revenue: 2115751 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-06-000082.txt#3095
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 2.9 million

Prior period

−USD 13.99 million

2004-01-01 – 2004-12-31
Current period

−USD 11.09 million

2005-01-01 – 2005-12-31

Exact inputs and evidence

-11088281 − -13989854 = 2901573 USD

-13989854 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
-11088281 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · AXM PHARMA INC · 2005-12-31 AXM PHARMA INC (edgar:1113643) Year-over-year change in Net income: 2901573 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -11088281 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-06-000082.txt#3257 Input fundies:NetIncome: -13989854 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-06-000082.txt#3257
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 5.03 million

Prior period

−USD 3.58 million

2004-01-01 – 2004-12-31
Current period

−USD 8.61 million

2005-01-01 – 2005-12-31

Exact inputs and evidence

-8611869 − -3584720 = -5027149 USD

-3584720 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
-8611869 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · AXM PHARMA INC · 2005-12-31 AXM PHARMA INC (edgar:1113643) Year-over-year change in Operating cash flow: -5027149 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -8611869 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-06-000082.txt#3275 Input fundies:OperatingCashFlow: -3584720 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-06-000082.txt#3275
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-93.4%

Prior period

USD 6.89 million

2004-01-01 – 2004-12-31
Current period

USD 453,943

2005-01-01 – 2005-12-31

Exact inputs and evidence

453943 − 6892907 = -6438964 USD

6892907 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
453943 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · AXM PHARMA INC · 2005-12-31 AXM PHARMA INC (edgar:1113643) Year-over-year change in Capital expenditure: -6438964 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 453943 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-06-000082.txt#3279 Input fundies:CapitalExpenditure: 6892907 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-06-000082.txt#3279
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2005 2005-01-01 – 2005-12-31

Revenue USD 2.02 million 100% of revenue
Operating costs Derived USD 10.88 million 538% of revenue
Operating income −USD 8.86 million −438% of revenue
Tax, interest and other Derived USD 2.23 million 110% of revenue
Net income −USD 11.09 million −548% of revenue

Cash

Operating cash flow −USD 8.61 million −426% of revenue
Capital expenditure USD 453,943 22% of revenue
Free cash flow Derived −USD 9.07 million −448% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2000 Operating loss: operating costs were 330% of revenue.
2001 Operating loss: operating costs were 1,345% of revenue.
2002 Not shown: operating income or net income is not reported.
2002 Not shown: operating income or net income is not reported.
2003 Not shown: operating income or net income is not reported.
2004 Operating loss: operating costs were 761% of revenue.
2005 Operating loss: operating costs were 538% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2000 1999-07-01 – 2000-06-30	3799	12521 Derived	-8722	-12 Derived	-8710	-23565 Derived	Source 1999-07-01 – 2000-06-30: 3799 USD Inspect Revenue Open source 1999-07-01 – 2000-06-30: -8722 USD Inspect Operating Income Open source 1999-07-01 – 2000-06-30: -8710 USD Inspect Net Income Open source 1999-07-01 – 2000-06-30: -3315 USD Inspect Operating Cash Flow Open source 1999-07-01 – 2000-06-30: 20250 USD Inspect Capital Expenditure Open source
2001 2000-07-01 – 2001-06-30	11945	160699 Derived	-148754	-80 Derived	-148674	-106341 Derived	Source 2000-07-01 – 2001-06-30: 11945 USD Inspect Revenue Open source 2000-07-01 – 2001-06-30: -148754 USD Inspect Operating Income Open source 2000-07-01 – 2001-06-30: -148674 USD Inspect Net Income Open source 2000-07-01 – 2001-06-30: -102095 USD Inspect Operating Cash Flow Open source 2000-07-01 – 2001-06-30: 4246 USD Inspect Capital Expenditure Open source
2002 2001-07-01 – 2002-06-30	0	21042 Derived	-21042	0 Derived	-21042	Unavailable	Source 2001-07-01 – 2002-06-30: 0 USD Inspect Revenue Open source 2001-07-01 – 2002-06-30: -21042 USD Inspect Operating Income Open source 2001-07-01 – 2002-06-30: -21042 USD Inspect Net Income Open source 2001-07-01 – 2002-06-30: 0 USD Inspect Operating Cash Flow Open source
2002 2002-01-01 – 2002-12-31	3103656	Unavailable	Unavailable	Unavailable	-52357	Unavailable	Source 2002-01-01 – 2002-12-31: 3103656 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -52357 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: 0 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	10025605	Unavailable	Unavailable	Unavailable	-3708067	Unavailable	Source 2003-01-01 – 2003-12-31: 10025605 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -3708067 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: 293654 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	2115751	16105605 Derived	-13989854	0 Derived	-13989854	-10477627 Derived	Source 2004-01-01 – 2004-12-31: 2115751 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -13989854 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -13989854 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -3584720 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 6892907 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	2021728	10878784 Derived	-8857056	2231225 Derived	-11088281	-9065812 Derived	Source 2005-01-01 – 2005-12-31: 2021728 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -8857056 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -11088281 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -8611869 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 453943 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2M 2005

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-06-30	Revenue	3799	Revenue: 3799 Open source
20012001-06-30	Revenue	11945	Revenue: 11945 Open source
20022002-06-30	Revenue	0	Revenue: 0 Open source
20022002-12-31	Revenue	3103656	Revenue: 3103656 Open source
20032003-12-31	Revenue	10025605	Revenue: 10025605 Open source
20042004-12-31	Revenue	2115751	Revenue: 2115751 Open source
20052005-12-31	Revenue	2021728	Revenue: 2021728 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-4.4% 2005

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20002000-06-30	Year over year	No prior comparable period	Revenue: 3799 Open source
20012001-06-30	Year over year	214.4%	Revenue: 11945 Open source Revenue: 3799 Open source
20022002-06-30	Year over year	-100%	Revenue: 0 Open source Revenue: 11945 Open source
20022002-12-31	Year over year	No prior comparable period	Revenue: 3103656 Open source
20032003-12-31	Year over year	223%	Revenue: 10025605 Open source Revenue: 3103656 Open source
20042004-12-31	Year over year	-78.9%	Revenue: 2115751 Open source Revenue: 10025605 Open source
20052005-12-31	Year over year	-4.4%	Revenue: 2021728 Open source Revenue: 2115751 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -438.1% 2005

Net margin -548.5% 2005

Free cash flow margin -448.4% 2005

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20002000-06-30	Operating margin	-229.6%	Operating Income: -8722 Open source Revenue: 3799 Open source
20012001-06-30	Operating margin	-1,245.3%	Operating Income: -148754 Open source Revenue: 11945 Open source
20022002-06-30	Operating margin	Not reported	Operating Income: -21042 Open source Revenue: 0 Open source
2002-12-31	Operating margin	Not reported	Revenue: 3103656 Open source
2003-12-31	Operating margin	Not reported	Revenue: 10025605 Open source
20042004-12-31	Operating margin	-661.2%	Operating Income: -13989854 Open source Revenue: 2115751 Open source
20052005-12-31	Operating margin	-438.1%	Operating Income: -8857056 Open source Revenue: 2021728 Open source
20002000-06-30	Net margin	-229.3%	Net Income: -8710 Open source Revenue: 3799 Open source
20012001-06-30	Net margin	-1,244.7%	Net Income: -148674 Open source Revenue: 11945 Open source
20022002-06-30	Net margin	Not reported	Net Income: -21042 Open source Revenue: 0 Open source
20022002-12-31	Net margin	-1.7%	Net Income: -52357 Open source Revenue: 3103656 Open source
20032003-12-31	Net margin	-37%	Net Income: -3708067 Open source Revenue: 10025605 Open source
20042004-12-31	Net margin	-661.2%	Net Income: -13989854 Open source Revenue: 2115751 Open source
20052005-12-31	Net margin	-548.5%	Net Income: -11088281 Open source Revenue: 2021728 Open source
20002000-06-30	Free cash flow margin	-620.3%	Revenue: 3799 Open source Operating Cash Flow: -3315 Open source Capital Expenditure: 20250 Open source
20012001-06-30	Free cash flow margin	-890.3%	Revenue: 11945 Open source Operating Cash Flow: -102095 Open source Capital Expenditure: 4246 Open source
20022002-06-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: 0 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 3103656 Open source Capital Expenditure: 0 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 10025605 Open source Capital Expenditure: 293654 Open source
20042004-12-31	Free cash flow margin	-495.2%	Revenue: 2115751 Open source Operating Cash Flow: -3584720 Open source Capital Expenditure: 6892907 Open source
20052005-12-31	Free cash flow margin	-448.4%	Revenue: 2021728 Open source Operating Cash Flow: -8611869 Open source Capital Expenditure: 453943 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -8.6M 2005

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-06-30	Operating cash flow	-3315	Operating Cash Flow: -3315 Open source
20012001-06-30	Operating cash flow	-102095	Operating Cash Flow: -102095 Open source
20022002-06-30	Operating cash flow	0	Operating Cash Flow: 0 Open source
20022002-12-31	Operating cash flow	Not reported	No source recorded
20032003-12-31	Operating cash flow	Not reported	No source recorded
20042004-12-31	Operating cash flow	-3584720	Operating Cash Flow: -3584720 Open source
20052005-12-31	Operating cash flow	-8611869	Operating Cash Flow: -8611869 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -9.1M 2005

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-06-30	Free cash flow	-23565	Operating Cash Flow: -3315 Open source Capital Expenditure: 20250 Open source
20012001-06-30	Free cash flow	-106341	Operating Cash Flow: -102095 Open source Capital Expenditure: 4246 Open source
20022002-06-30	Free cash flow	Unavailable	Operating Cash Flow: 0 Open source
20022002-12-31	Free cash flow	Unavailable	Capital Expenditure: 0 Open source
20032003-12-31	Free cash flow	Unavailable	Capital Expenditure: 293654 Open source
20042004-12-31	Free cash flow	-10477627	Operating Cash Flow: -3584720 Open source Capital Expenditure: 6892907 Open source
20052005-12-31	Free cash flow	-9065812	Operating Cash Flow: -8611869 Open source Capital Expenditure: 453943 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2000-06-30	Liabilities / assets	Not reported	Total Assets: 17208 Open source
2001-06-30	Liabilities / assets	Not reported	Total Assets: 12522 Open source
2002-06-30	Liabilities / assets	Not reported	Total Assets: 0 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 0 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 11024738 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 12340946 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 13833946 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.31× 2005

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2000-06-30	Current assets / current liabilities	Not reported	Current Liabilities: 1518 Open source
20012001-06-30	Current assets / current liabilities	5.31×	Current Assets: 8065 Open source Current Liabilities: 1518 Open source
2002-06-30	Current assets / current liabilities	Not reported	Current Liabilities: 2625 Open source
2002-12-31	Current assets / current liabilities	Not reported	Current Liabilities: 4838 Open source
20032003-12-31	Current assets / current liabilities	2.69×	Current Assets: 9275214 Open source Current Liabilities: 3441990 Open source
20042004-12-31	Current assets / current liabilities	0.7×	Current Assets: 3730682 Open source Current Liabilities: 5346696 Open source
20052005-12-31	Current assets / current liabilities	0.31×	Current Assets: 4060322 Open source Current Liabilities: 12969219 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2000 1999-07-01 – 2000-06-30	−USD 8,710 Exact value Exact value: -8710 USD 1999-07-01 – 2000-06-30: -8710 USD Inspect Net Income Open source Share or cite Citation for Net Income · AXM PHARMA INC · 2000-06-30 AXM PHARMA INC (edgar:1113643) Net Income: -8710 USD Concept: fundies:NetIncome Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643/explain?concept=fundies%3ANetIncome&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:NetIncome: -8710 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001026700-01-500206.txt#793 The citation records this snapshot. The page link may show a newer release later.	−USD 3,315 Exact value Exact value: -3315 USD 1999-07-01 – 2000-06-30: -3315 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AXM PHARMA INC · 2000-06-30 AXM PHARMA INC (edgar:1113643) Operating Cash Flow: -3315 USD Concept: fundies:OperatingCashFlow Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643/explain?concept=fundies%3AOperatingCashFlow&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3315 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001026700-01-500206.txt#802 The citation records this snapshot. The page link may show a newer release later.	USD 20,250 Exact value Exact value: 20250 USD 1999-07-01 – 2000-06-30: 20250 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AXM PHARMA INC · 2000-06-30 AXM PHARMA INC (edgar:1113643) Capital Expenditure: 20250 USD Concept: fundies:CapitalExpenditure Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643/explain?concept=fundies%3ACapitalExpenditure&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 20250 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001026700-01-500206.txt#807 The citation records this snapshot. The page link may show a newer release later.	−USD 23,565 Calculation and evidence -3315 − 20250 USD Exact free cash flow: -23565 USD 1999-07-01 – 2000-06-30: -3315 USD · Inspect Operating Cash Flow · Source 1999-07-01 – 2000-06-30: 20250 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AXM PHARMA INC · 2000-06-30 AXM PHARMA INC (edgar:1113643) Free cash flow: -23565 USD Concept: free-cash-flow Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3315 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001026700-01-500206.txt#802 Input fundies:CapitalExpenditure: 20250 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001026700-01-500206.txt#807 The citation records this snapshot. The page link may show a newer release later.
2001 2000-07-01 – 2001-06-30	−USD 148,674 Exact value Exact value: -148674 USD 2000-07-01 – 2001-06-30: -148674 USD Inspect Net Income Open source Share or cite Citation for Net Income · AXM PHARMA INC · 2001-06-30 AXM PHARMA INC (edgar:1113643) Net Income: -148674 USD Concept: fundies:NetIncome Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643/explain?concept=fundies%3ANetIncome&period=2001-06-30&surface=latest&period_type=duration&start=2000-07-01&unit=USD&dimensions= Input fundies:NetIncome: -148674 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-03-000007.txt#975 The citation records this snapshot. The page link may show a newer release later.	−USD 102,095 Exact value Exact value: -102095 USD 2000-07-01 – 2001-06-30: -102095 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AXM PHARMA INC · 2001-06-30 AXM PHARMA INC (edgar:1113643) Operating Cash Flow: -102095 USD Concept: fundies:OperatingCashFlow Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643/explain?concept=fundies%3AOperatingCashFlow&period=2001-06-30&surface=latest&period_type=duration&start=2000-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -102095 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-03-000007.txt#985 The citation records this snapshot. The page link may show a newer release later.	USD 4,246 Exact value Exact value: 4246 USD 2000-07-01 – 2001-06-30: 4246 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AXM PHARMA INC · 2001-06-30 AXM PHARMA INC (edgar:1113643) Capital Expenditure: 4246 USD Concept: fundies:CapitalExpenditure Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643/explain?concept=fundies%3ACapitalExpenditure&period=2001-06-30&surface=latest&period_type=duration&start=2000-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4246 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-03-000007.txt#989 The citation records this snapshot. The page link may show a newer release later.	−USD 106,341 Calculation and evidence -102095 − 4246 USD Exact free cash flow: -106341 USD 2000-07-01 – 2001-06-30: -102095 USD · Inspect Operating Cash Flow · Source 2000-07-01 – 2001-06-30: 4246 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AXM PHARMA INC · 2001-06-30 AXM PHARMA INC (edgar:1113643) Free cash flow: -106341 USD Concept: free-cash-flow Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -102095 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-03-000007.txt#985 Input fundies:CapitalExpenditure: 4246 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-03-000007.txt#989 The citation records this snapshot. The page link may show a newer release later.
2002 2001-07-01 – 2002-06-30	−USD 21,042 Exact value Exact value: -21042 USD 2001-07-01 – 2002-06-30: -21042 USD Inspect Net Income Open source Share or cite Citation for Net Income · AXM PHARMA INC · 2002-06-30 AXM PHARMA INC (edgar:1113643) Net Income: -21042 USD Concept: fundies:NetIncome Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643/explain?concept=fundies%3ANetIncome&period=2002-06-30&surface=latest&period_type=duration&start=2001-07-01&unit=USD&dimensions= Input fundies:NetIncome: -21042 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-03-000007.txt#975 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2001-07-01 – 2002-06-30: 0 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AXM PHARMA INC · 2002-06-30 AXM PHARMA INC (edgar:1113643) Operating Cash Flow: 0 USD Concept: fundies:OperatingCashFlow Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643/explain?concept=fundies%3AOperatingCashFlow&period=2002-06-30&surface=latest&period_type=duration&start=2001-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 0 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-03-000007.txt#985 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2002-01-01 – 2002-12-31	−USD 52,357 Exact value Exact value: -52357 USD 2002-01-01 – 2002-12-31: -52357 USD Inspect Net Income Open source Share or cite Citation for Net Income · AXM PHARMA INC · 2002-12-31 AXM PHARMA INC (edgar:1113643) Net Income: -52357 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -52357 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-04-000246.txt#3348 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 0 Exact value Exact value: 0 USD 2002-01-01 – 2002-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AXM PHARMA INC · 2002-12-31 AXM PHARMA INC (edgar:1113643) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-04-000246.txt#3368 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2003 2003-01-01 – 2003-12-31	−USD 3.71 million Exact value Exact value: -3708067 USD 2003-01-01 – 2003-12-31: -3708067 USD Inspect Net Income Open source Share or cite Citation for Net Income · AXM PHARMA INC · 2003-12-31 AXM PHARMA INC (edgar:1113643) Net Income: -3708067 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3708067 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-04-000246.txt#3348 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 293,654 Exact value Exact value: 293654 USD 2003-01-01 – 2003-12-31: 293654 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AXM PHARMA INC · 2003-12-31 AXM PHARMA INC (edgar:1113643) Capital Expenditure: 293654 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 293654 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-04-000246.txt#3368 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2004 2004-01-01 – 2004-12-31	−USD 13.99 million Exact value Exact value: -13989854 USD 2004-01-01 – 2004-12-31: -13989854 USD Inspect Net Income Open source Share or cite Citation for Net Income · AXM PHARMA INC · 2004-12-31 AXM PHARMA INC (edgar:1113643) Net Income: -13989854 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13989854 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-06-000082.txt#3257 The citation records this snapshot. The page link may show a newer release later.	−USD 3.58 million Exact value Exact value: -3584720 USD 2004-01-01 – 2004-12-31: -3584720 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AXM PHARMA INC · 2004-12-31 AXM PHARMA INC (edgar:1113643) Operating Cash Flow: -3584720 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3584720 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-06-000082.txt#3275 The citation records this snapshot. The page link may show a newer release later.	USD 6.89 million Exact value Exact value: 6892907 USD 2004-01-01 – 2004-12-31: 6892907 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AXM PHARMA INC · 2004-12-31 AXM PHARMA INC (edgar:1113643) Capital Expenditure: 6892907 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6892907 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-06-000082.txt#3279 The citation records this snapshot. The page link may show a newer release later.	−USD 10.48 million Calculation and evidence -3584720 − 6892907 USD Exact free cash flow: -10477627 USD 2004-01-01 – 2004-12-31: -3584720 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 6892907 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AXM PHARMA INC · 2004-12-31 AXM PHARMA INC (edgar:1113643) Free cash flow: -10477627 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3584720 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-06-000082.txt#3275 Input fundies:CapitalExpenditure: 6892907 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-06-000082.txt#3279 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 11.09 million Exact value Exact value: -11088281 USD 2005-01-01 – 2005-12-31: -11088281 USD Inspect Net Income Open source Share or cite Citation for Net Income · AXM PHARMA INC · 2005-12-31 AXM PHARMA INC (edgar:1113643) Net Income: -11088281 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11088281 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-06-000082.txt#3257 The citation records this snapshot. The page link may show a newer release later.	−USD 8.61 million Exact value Exact value: -8611869 USD 2005-01-01 – 2005-12-31: -8611869 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AXM PHARMA INC · 2005-12-31 AXM PHARMA INC (edgar:1113643) Operating Cash Flow: -8611869 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8611869 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-06-000082.txt#3275 The citation records this snapshot. The page link may show a newer release later.	USD 453,943 Exact value Exact value: 453943 USD 2005-01-01 – 2005-12-31: 453943 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AXM PHARMA INC · 2005-12-31 AXM PHARMA INC (edgar:1113643) Capital Expenditure: 453943 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 453943 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-06-000082.txt#3279 The citation records this snapshot. The page link may show a newer release later.	−USD 9.07 million Calculation and evidence -8611869 − 453943 USD Exact free cash flow: -9065812 USD 2005-01-01 – 2005-12-31: -8611869 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 453943 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AXM PHARMA INC · 2005-12-31 AXM PHARMA INC (edgar:1113643) Free cash flow: -9065812 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:01:41Z Snapshot: 3da585cd7e6356c7a43a103bda8af57eafd9323223559114ed5814844eb0a779 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1113643?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8611869 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-06-000082.txt#3275 Input fundies:CapitalExpenditure: 453943 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1113643/0001121781-06-000082.txt#3279 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

33 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001113643, 1113643, edgar:1113643

Also known as AXIOM PHARMACEUTICALS INC, WHOLE SALE ON THE NET INC, WICKLIFFE INTERNATIONAL CORP

AXM PHARMA INC

Latest quarter

Revenue

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2005 2005-01-01 – 2005-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation